Sale!

ACTN1 Gene Bleeding Disorder Platelet-Type 15 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “ACTN1 Gene Bleeding Disorder Platelet-Type 15 Genetic Test” is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the ACTN1 gene that are associated with Platelet-Type 15 Bleeding Disorder. This condition is a rare genetic disorder that affects platelet function, leading to bleeding complications. The ACTN1 gene plays a critical role in the formation and stabilization of platelet cytoskeleton, which is essential for proper platelet aggregation and clot formation. Mutations in this gene can disrupt these processes, resulting in increased bleeding risk.

The test is crucial for individuals who have a family history of bleeding disorders or have experienced symptoms such as easy bruising, frequent nosebleeds, heavy menstrual bleeding, or prolonged bleeding from minor wounds. Early diagnosis through this genetic test can facilitate appropriate management strategies and prevent complications.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures accuracy and confidentiality. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to analyze the genetic variations accurately. This investment in health can provide invaluable peace of mind and direction for managing the condition effectively.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ACTN1 Gene Bleeding disorder platelet-type 15 Genetic Test

Are you concerned about a possible bleeding disorder? DNA Labs UAE offers the ACTN1 Gene Bleeding disorder platelet-type 15 Genetic Test to provide you with accurate and reliable results. Read on to learn more about this test and its significance in diagnosing platelet-type 15.

Test Details

The ACTN1 gene is responsible for producing a protein called alpha-actinin-1, which plays a crucial role in the structure and function of platelets. Platelets are blood cells that are essential for blood clotting. When there are mutations in the ACTN1 gene, it can lead to a bleeding disorder known as platelet-type 15.

Platelet-type 15 is an inherited condition characterized by abnormal platelet function, which increases the risk of bleeding. Individuals with this condition may experience symptoms such as easy bruising, nosebleeds, prolonged bleeding after injuries or surgeries, and heavy or prolonged menstrual periods.

Our ACTN1 Gene Bleeding disorder platelet-type 15 Genetic Test utilizes NGS (Next-Generation Sequencing) technology. NGS genetic testing allows for the analysis of multiple genes simultaneously to identify mutations or variations in the DNA sequence. In the case of platelet-type 15, this test specifically focuses on identifying mutations in the ACTN1 gene associated with the bleeding disorder.

By identifying these mutations, our NGS genetic testing can aid in the diagnosis of individuals with platelet-type 15. It also provides valuable information for treatment and management strategies. Additionally, this test can be used for carrier testing in families with a history of the condition, enabling informed family planning decisions.

It’s important to note that genetic testing should always be performed and interpreted by qualified healthcare professionals. Our team of expert hematologists in the Genetics department will ensure accurate testing, provide appropriate counseling, and offer guidance based on the test results.

Test Components and Price

The ACTN1 Gene Bleeding disorder platelet-type 15 Genetic Test is priced at 4400.0 AED. This cost includes all necessary components for the test.

Sample Condition

The sample required for this test is blood. Our laboratory will provide detailed instructions on how to collect and preserve the sample to ensure accurate results.

Report Delivery

After the sample is received and analyzed, the report will be delivered within 3 to 4 weeks. We understand the importance of timely results and strive to provide them as efficiently as possible.

Pre Test Information

Prior to undergoing the ACTN1 Gene Bleeding disorder platelet-type 15 Genetic Test, it is essential to provide a clinical history of the patient. This information will help our hematologists in understanding the patient’s background and guide them in the interpretation of the test results.

Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by the ACTN1 Gene Bleeding disorder platelet-type 15. This session ensures comprehensive testing and helps identify any potential patterns or risks within the family.

By opting for the ACTN1 Gene Bleeding disorder platelet-type 15 Genetic Test at DNA Labs UAE, you can gain valuable insights into your genetic makeup and make informed decisions regarding your health and family planning. Our dedicated team of experts is committed to providing accurate results and comprehensive guidance throughout the testing process.

Test Name ACTN1 Gene Bleeding disorder platelet-type 15 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hematology
Doctor Hematologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ACTN1 Gene Bleeding disorder, platelet-type 15 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ACTN1 Gene Bleeding disorder, platelet-type 15 NGS Genetic DNA Test gene ACTN1
Test Details

The ACTN1 gene is responsible for producing a protein called alpha-actinin-1, which plays a role in the structure and function of platelets. Platelets are blood cells involved in blood clotting. Mutations in the ACTN1 gene can lead to a bleeding disorder known as platelet-type 15.

Platelet-type 15 is an inherited condition characterized by abnormal platelet function, leading to an increased risk of bleeding. Individuals with this condition may experience easy bruising, nosebleeds, prolonged bleeding after injuries or surgeries, and heavy or prolonged menstrual periods.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify mutations or variations in the DNA sequence. In the case of platelet-type 15, NGS genetic testing can be used to identify mutations in the ACTN1 gene that are associated with the bleeding disorder.

By identifying these mutations, NGS genetic testing can help diagnose individuals with platelet-type 15 and provide valuable information for treatment and management strategies. It can also be used for carrier testing in families with a history of the condition, allowing for informed family planning decisions.

It’s important to note that genetic testing should always be performed and interpreted by qualified healthcare professionals who can provide appropriate counseling and guidance based on the results.